American Society of Clinical Oncology (ASCO)

The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, it has nearly 45,000 members worldwide.

Results from the ARCHER 1009 Study: Dacomitinib Versus Erlotinib for Second-/Third-Line Therapy of Locally Advanced or Metastatic NSCLC

ASCO 2014 – Lung Cancer

Results from PROFILE 1014: First-Line Crizotinib Versus Pemetrexed-Platinum in ALK+ NSCLC

ASCO 2014 – Lung Cancer

Erlotinib Plus Bevacizumab as First-Line Treatment for EGFR+, Advanced NSCLC

ASCO 2014 – Lung Cancer

Phase 2 Trial of Nivolumab in Metastatic Renal Cell Carcinoma

ASCO 2014 – Immuno-Oncology

Ceritinib in Advanced ALK-Rearranged NSCLC: Results from the ASCEND-1 Trial

ASCO 2014 – Lung Cancer

Docetaxel and Cisplatin Plus Chemoradiation in Inoperable Stage III NSCLC

ASCO 2014 – Lung Cancer

Results from RADIANT: Adjuvant Erlotinib in NSCLC

ASCO 2014 – Lung Cancer

Breaking News from the REVEL Study in NSCLC

ASCO 2014 – Lung Cancer

NSCLC Daily News from ASCO 2014: May 30, 2014 – Preview of Key Topics

ASCO 2014 – Lung Cancer

Next-Generation TKIs

ASCO 2014 – Lung Cancer

Page 28 of 33

25
26
27
28
29
30
31

Conference Coverage Proudly Presented by

American Health & Drug Benefits

Journal of Hematology Oncology Pharmacy

Journal of Oncology Navigation & Survivorship

Oncology Practice Management

Personalized Medicine in Oncology

The Oncology Nurse–APN/PA

The Oncology Pharmacist

Value-Based Cancer Care

Learn more about our family of publications.

View Our Publications